The AD-specific upregulation of Cxcl16 in CPM, IRM and TM cell clusters in the dataset from Sierksma et al., 2020 suggests that the expression of mutant APP and PSEN1 transgenes is one of the main drivers of Cxcl16 production. This evidence concerns the gene APP and Alzheimer disease.